Congressional Testimony 2016

This section includes testimony by FDA officials before House and Senate Committees and Subcommittees.

December 2016

12/07/2016 Waste and Duplication in the USDA Catfish Inspection Program William R. Jones, Ph. D, before the Committee on Energy and Commerce, U.S. House of Representatives

09/22/2016 Exploring a Right to Try for Terminally Ill Patients Peter Lurie, M.D., M.P.H., before the Committee on Homeland Security and Government Affairs, U.S. Senate
09/21/2016 Reviewing the Rising Price of EpiPens Douglas Throckmorton, M.D., before the Committee on Oversight and Government Reform, U.S. House of Representatives
09/21/2016 Prioritizing Public Health: The FDA’s Role in the Generic Drug Marketplace Janet Woodcock, M.D., before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Committee on Appropriations; U.S. Senate

07/13/2016 Researching the Potential Medical Benefits and Risks of Marijuana Douglas Throckmorton, M.D., before the Committee on the Judiciary, U.S. Senate

06/14/2016 Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development Janet Woodcock, M.D. before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
06/07/2016 Deadly Synthetic Drugs: The Need to Stay Ahead of the Poison Peddlers Douglas Throckmorton, M.D., before the Committee on the Judiciary, U.S. Senate

05/19/2016 Strengthening Public Health Emergency Response Act of 2015 Michael Mair, MPH, before the House Subcommittee on Health, Committee on Energy & Commerce

04/20/2016 How Secure are U.S. Bioresearch Labs? Preventing the Next Safety Lapse Segaran Pillai, Ph.D., before the House Energy & Commerce Committee, Subcommittee on Oversight and Investigations

03/02/2016 Examining the U.S. Public Health Response to the Zika Virus Luciana Borio, M.D., before the House Energy and Commerce Committee, Subcommittee on Oversight and Investigations
03/02/2016 President's Fiscal Year 2017 Budget Request (Senate) Robert Califf, M.D., before the Senate Appropriations Committee, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

President's Fiscal Year 2017 Budget Request (House) Stephen Ostroff, M.D., before the Committee on Appropriations; Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; U.S. House of Representatives
02/04/2016 Biosimilars Implementation Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
02/04/2016 Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA) Janet Woodcock, M.D., before the House Committee on Oversight and Government Reform

01/28/2016 Implementation of the Generic Drug User Fee Amendments of 2012 (GDUFA) Janet Woodcock, M.D., before the Senate Committee on Health, Education, Labor and Pensions